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Objective. Despite broad research in neurotrauma and shock, little is known on systemic inﬂammatory eﬀects of the clinically
most relevant combined polytrauma. Experimental investigation in an animal model may provide relevant insight for therapeutic
strategies. We describe the eﬀects of a combined injury with respect to lymphocyte population and cytokine activation. Methods.
45 male C57BL/6J mice (mean weight 27g) were anesthetized with ketamine/xylazine. Animals were subjected to a weight drop
closed traumatic brain injury (WD-TBI), a femoral fracture and hemorrhagic shock (FX-SH). Animals were subdivided into WD-
TBI, FX-SH and combined trauma (CO-TX) groups. Subjects were sacriﬁced at 96h. Blood was analysed for cytokines and by
ﬂow cytometry for lymphocyte populations. Results. Mortality was 8%, 13% and 47% for FX-SH, WD-TBI and CO-TX groups
(P<0.05). TNFα (11/13/139 for FX-SH/WD-TBI/CO-TX; P<0.05), CCL2 (78/96/227; P<0.05) and IL-6 (16/48/281; P = 0.05)
showed signiﬁcant increases in the CO-TX group. Lymphocyte populations results for FX-SH, WD-TBI and CO-TX were: CD-4
(31/21/22; P = n.s.), CD-8 (7/28/34, P<0.05), CD-4-CD-8 (11/12/18; P = n.s.), CD-56 (36/7/8; P<0.05). Conclusion. This
study shows that a combination of closed TBI and femur-fracture/ shock results in an increase of the humoral inﬂammation. More
attention to combined injury models in inﬂammation research is indicated.
1.Introduction
Trauma and especially multiple trauma including traumatic
brain injury (TBI) are the most common killers in children
and adults before age 50 around the world [1–3]. Mortality
of multiple trauma including TBI following traﬃca c c i d e n t s
ranges between 18% and 25% [1, 4]. But not only the
ﬁrst hours and days are critical; for years, more and more
multiple trauma patients have been surviving the initial
accident and acute care period but only to develop systemic
inﬂammatory response syndrome (SIRS), sepsis, or multiple
organ dysfunction syndrome (MODS) in the course of the
few weeks of critical care [2, 5, 6].
For 5000 multiple trauma patients in Germany, the
German Trauma Registry showed an in-hospital mortality of
12% in 2010. In the same report, critical care complications
such as SIRS, sepsis, and MODS are reported for 15% of
patients. Other groups report similar rates of SIRS, sepsis,
and MODS [2, 6, 7]. It is generally known that these
complications again deteriorate the prognosis and outcome
of the initially surviving trauma patient and increase late
mortality to up to 50% if manifest MODS is developed
[2, 7, 8].
To understand pathophysiological processes leading to
multiple organ failure, SIRS, and sepsis and taking place
during this devastating illness, profound pathophysiological2 Mediators of Inﬂammation
knowledge on the eﬀects of the initial trauma (“ﬁrst hit”)
is essential to minimize additional harm by the following
surgicalorcriticalcaretreatment(potential“secondhit”)[9–
11].
Therefore, numerous neurotrauma as well as shock re-
search studies with many diﬀerent animal and clinical mod-
elsshowedinﬂammatorychangesaftertrauma[12–14].Only
recently, Semple et al. reported on the important role of
CCL2 in C57Bl/J6 mice, peaking at 4 to 12h following closed
headinjuryandleadingtoimprovedfunctionaloutcomeand
l e s i o ns i z er e d u c t i o na sw e l la sl e s ss e c o n d a r yb r a i nd a m a g e
[15]. Another group showed that the substance Minozac
may attenuate the eﬀect of proinﬂammatory cytokines after
closed TBI in mice. In the same study, the authors discussed
if Minozac may also increase long-term neurofunction after
TBI [16]. On the other hand, femur fracture and shock in
mice are known to trigger an inﬂammatory response for
years,andrecentlyseveralgroupsdiscussedtherapeuticstrat-
egies to modulate this inﬂammatory response [12, 14].
However, little attention has been paid to the immune
reaction following combined trauma and the interaction of
the brain and the other organs of the body. This is even
more important, since the injury pattern of closed TBI,
lower extremity fracture, and shock is very common in
multiply injured patients treated in trauma centers around
the world. Therefore, we investigated the humoral and
cellular inﬂammatory changes of the combined TBI, shock,
and femur fracture in a polytrauma model of the mouse.
2.MaterialandMethods
2.1. Animal Care. The study was approved by the Animal
ResearchCommitteeoftheHannoverMedicalSchool(Medi-
zinische Hochschule Hannover, MHH) and the county gov-
ernment of Lower Saxony (Bezirksregierung Niedersachsen),
no. 03/672.
45 male C57BL/J6 mice aged 8–10 weeks with a mean
weight of 27.4g (±3.7g) were used for the study. The
animals were bred and raised in the central animal facility
of our institution. All animals were handled at room
temperature for 7 days before treatment. Throughout the
studyperiod,pelletedmousefeed(Altromin1324)andwater
were available ad libitum. The lighting was maintained on
a 12-hour cycle. Room temperature was maintained at a
constant 20◦± 2◦C.
2.2. Anesthesia. Analgetic therapy during the whole time
of the study was provided by Metamizol 25mg/1000mL
(Novaminsulfon ratiopharm, Ratiopharm GmbH, Ulm) in
the drinking water of the animals ad libitum.
A l ls u r g i c a la n dt r a u m ap r o c e d u r e sw e r ep e r f o r m e d
at a level of deep surgical anesthesia during maintained
spontaneous breathing. For anesthesia, subcutaneous injec-
tion of Ketamine (Ketanest, Parke-Davis GmbH, Karlsruhe,
Germany) with a dose of 100mg/kg body weight and
2% Xylazine (Rompun, Bayer Vital GmbH, Leverkusen,
Germany) with a dose of 16mg/kg body weight were used.
The eyes of the animals were covered by Dexpanthenol
(Bepanthen, Hoﬀmann-La Roche AG, Grenzach-Wyhlen,
Switzerland). The trauma and perioperative care was per-
formed under an infrared heating lamp. Thereby body
temperature of 36◦C could be maintained.
2.3. Weight Drop Traumatic Brain Injury (WD-TBI). 30 of
the animals underwent a standard WD-TBI following a
model published previously by Shapira et al. [17]w i t h
modiﬁcation according to Chen et al. [18]. Under a surgical
level of anesthesia, the animal was positioned in a stereotaxic
frame,theheadwasshaved,andtheexposedscalpdisinfected
by Softasept N (Braun, Melsungen, Germany). A midline
incision was performed, and the skull was exposed. Next, the
3mm diameter probe was positioned on the planned impact
point at the left of the sagittal suture and caudad to the
coronal suture. The trauma was now performed with a mean
velocity of 3m/s by a software-guided process (“Labview,”
National Instruments, Austin, TX, USA).
Animals were taken out from the stereotaxic frame while
still anesthetized. The wound was irrigated and closed by
4.0 prolene sutures. (Ethicon, Norderstedt, Germany). After-
wards, the animals remained under continuous observation
and warming until full recovery was reached.
2.4. Femur Fracture. Femur fracture was applied by a blunt
guillotine device according to Van Griensven et al. [19], We
used a weight of 400g falling out of a height of 160mm
on the ﬁxed femur. Success of the fracture mechanism
was controlled clinically (crepitation and instability), while
the animal was still in anesthesia. If both of the clinical
signs were absent, the trauma was repeated. The repeated
procedure was required in one animal only. The guillotine
procedure resulted in an A-type femur fracture combined
with a moderate soft tissue injury. After completion of the
injury, we performed a closed reduction and splinting of
the fracture by a piece of wood in proper length that was
tied to the fractured extremity proximally and distally of the
fracture.
2.5. Shock. After both traumata were set, we draw 60% of
the blood volume of the respective mouse via an orbital
puncture with a heparinized capillary. Volume was restored
after 1 hour of shock with Ringer’s solution four times
the extracted blood volume into the tail vein. This resulted
in an individual resuscitation procedure. Only after this
resuscitation was completed and the animal showed 36◦Co f
body temperature, anesthesia was terminated and the animal
awoke [19].
2.6. Analysis of the Cytokines and Lymphocytes. Subjects were
sacriﬁced 96 hours after trauma by exsanguination in deep
surgical anaesthesia, while blood samples for cytokines were
extracted. As well the spleen was harvested, and a suspension
was produced. This suspension was used for lymphocyte
analysisasdescribedearlier[19].Lymphocyteswereanalyzed
using standard ﬂow cytometry (FACS analysis) for CD-4,
CD-8, CD-4-CD-8, and CD-56 cells (FACS Calibur, BDMediators of Inﬂammation 3
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Figure 1: Mortality rates (%) of the 3 trauma subgroups. FX-SH:
femur fracture and shock; WD-TBI: weight drop traumatic brain
injury; CO-TX: combined injuries. (∗)P = 0.0263. The CO-TX
group showed a signiﬁcantly higher mortality.
Biosciences, Heidelberg, Germany). The procedures have
been described earlier [19].
Serum cytokines (tumor necrosis factor α,T N F α;c h e
mokine CC2 ligand, CCL2; interleukins 6 and 12, IL-6 and
IL-12) were analyzed by cytometric bead array technique
(BDTM Cytometric Bead Array Mouse Inﬂammation Kit,
BD Biosciences, Pharmingen, Germany) and FACS as de-
scribed earlier [19].
2.7. Statistics. Analysis of continuous parameters was by
ANOVA and a post hoc Tukey test. Mortality ratios were
analyzed by chi-squared test. Results are reported as mean
± standard error of the mean (SEM). For statistical analysis,
SPSS 14.0 software was used. Statistical signiﬁcance was set
at P<0.05.
3. Results
3.1. Mortality. The polytraumatized animals showed a sig-
niﬁcantly higher mortality than the animals of both singular
trauma groups (Figure 1). There was no immediate death.
Deaths occurred between 24 and 72 hours after trauma.
3.2. Humoral Inﬂammatory Markers. TNFα, CCL2, and IL-
6 showed signiﬁcantly higher concentrations at 96h after
trauma in the CO-TX group, while the single-trauma groups
seem to raise their cytokine levels clearly less and without
signiﬁcant diﬀerences between groups WD-TBI and FX-
SH (Figure 2). IL-12 showed no diﬀerence in plasma
concentration between the groups at 96h after trauma.
3.3. Lymphocyte Populations. The CD-8 ratio was signiﬁ-
cantly lower, and the CD-56 ratio was signiﬁcantly higher
in the FX-SH mice than in each of the other groups. CD-4
and CD-4-CD-8 ratios showed no diﬀerence between groups
(Figure 3).
4. Discussion
While the intracranial eﬀects of traumatic brain injury have
been a subject of multiple studies, the aim of this study was
to investigate the interaction of the brain injury and systemic
shock after lower extremity trauma in regard to changes in
the inﬂammatory response.
Our main results were:
(1) increased levels of TNFα, CCL2, and IL-6 in the CO-
TX group,
(2) lower rates of CD-8 and higher rates of CD-56 cells
in the FX-SH group,
(3) an increased mortality in the combined trauma ani-
mal group.
However, some weaknesses of our study have to be kept
in mind. As always in animal studies, the ﬁndings cannot
completely be extrapolated to human pathophysiology and
clinical treatment strategies. Nonetheless, mouse models are
very common due to their availability, ease of handling,
and practicability. Anyhow, a correlation with similar large
animalmodelsandadditionalstudiesinhumansarerequired
to complete our ﬁndings and value the clinical relevance.
Furthermore, the injury pattern may seem artiﬁcial in its
constellation since one huge challenge of human polytrauma
studies is the diversity of injury patters requiring complex
inclusion and exclusion procedures to gain comparable
populations in terms of injury severity and injury pattern.
However, in our point of view, this strengthens our study:
the injury pattern and severity of our individuals is highly
standardized, and the model and both its components are
robust and reproducible. So comparability of our injuries
and populations is granted, even more so with regard to the
complex hypothesis of a combined trauma being more than
only the sum of its parts. This holds even true for standard
parameterssuchasweight,size,sex,andage,thatusuallyalso
aﬀect human studies of polytrauma patients.
Our ﬁrst ﬁnding supports any injury severity-related
changes in inﬂammatory response reported from humans
[2, 20–22]. Our CO-TX group simply suﬀered more severe
injuries than the FX-SH and WD-TBI groups. Looking at
each monotrauma, our plasma cytokine levels are compara-
ble to those reported earlier in literature [12, 14]. However,
the levels of the proinﬂammatory cytokines are elevated
not only by factor 2 but by factors 3 to 10, respectively,
even as late as 96 hours after trauma. Other groups found
similar results: TNFα was associated with injury severity
earlier. Likewise, in a murine trauma-haemorrhage model,
other authors reported TNFα elevations [23, 24]. The same
holds true for TBI in humans [25, 26] and clinically relevant
models of TBI [27]. While these groups reported elevated
TNFα levels 1 to 4h after trauma, later publications also
found TNFα eﬀects on neuronal recovery and prevention of
secondary brain damage [28]. One group reported elevated
plasma TNFα levels after TBI. So, while the importance
of TNFα after peripheral or brain injury remains rather
clear and reciprocal eﬀects were described to some extent,
we found no earlier report on the extent of TNFα plasma
level rise after combined TBI and trauma haemorrhage.
Concerning IL-6, Maegele et al. reported a 3-4 fold increase
in circulating plasma levels after combined fracture and ﬂuid
p e r c u s s i o nT B Ii nr a t s[ 29]. In humans, IL-6 was classiﬁed4 Mediators of Inﬂammation
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Figure 2: Cytokine levels (pg/mL) of the three subgroups. FX-SH: femur fracture and shock; WD-TBI: weight drop traumatic brain injury;
CO-TX: combined injuries. (∗)P<0.05.
as the most important secondary cytokine in trauma [30],
not only because of its multitude of mainly proinﬂammatory
eﬀects and its association to the severity of trauma, but
also because of its prognostic relevance diﬀering survivors
and nonsurvivors. So, highest IL-6 levels in the most severe
trauma group and the highest mortality are in line with
earlier results in literature. However, the magnitude of the
increase was rarely described. Similarly, CCL-2 is increased
in the brain after TBI and leads to increased migration
of intravascular leukocytes across a damaged blood-brain
barrier [31, 32]. As well CCL-2 was found to play a
key role in the development of organ dysfunction after
trauma by activating monocytes/macrophages to migrate
from the intravascular space into peripheral tissues. While
Thibeault et al. showed no association between IL-6 and
CCL-2 after trauma, they could show such an association
between TNFα and CCL-2 [33]. So, while being in line
with recent literature, our ﬁndings also remain conclusive
within themselves with respect to the inﬂammatory cascades
described earlier. With respect to proinﬂammatory IL-12,
ournonsigniﬁcantlylowserumlevelsarebackedupbyrecent
literature. In TBI, one author described diﬀerences in IL-
12 after 24h but not later [30]. In human multiple trauma
patients suﬀering from chest trauma, IL-12 was reported
to inversely correlate with mortality [30]. Furthermore, IL-
12 seems to exert some major eﬀects via CD56+-(NK-)
cells [30]. However, depressed IL-12 production in trauma
patients was associated with a shift towards a CD4+(TH2)
type pattern of adverse clinical outcome [30].
While numerous reports focus on intravascular lympho-
cyte populations and function after trauma, the populations
crucial for MODS to develop are those in peripheral tissues
[30]. The signiﬁcant decrease of the CD-8+ ratio in the
splenic suspension of our FX-SH group is supported by the
earlier ﬁnding of a decreased ratio of CD-8+ lymphocytes
in peripheral tissues after trauma hemorrhage compared to
controls [34]. However, we found no report on lymphocyte
populationsinperipheraltissuesaftertraumaticbraininjury.
Yet, the WD-TBI group might be comparable to controls for
peripheral trauma and hemorrhage (our FX-SH group) and
therefore shows higher CD-8+ ratios. Still, this hypothesis
does not explain the CD-8+ ratio of the CO-TX group.
Restoration of the low CD-8+ ratio after FX-SH by WD-
TBI might be speculated on but so far no theory on
responsible mechanisms is known. Since this result was
rather surprising for our group, detailed evaluation of key
processesforlymphocytepopulationsaftercombinedneuro-
and peripheral trauma and hemorrhage must be left for
future experiments. CD-56-(NK-) cells were found in a
signiﬁcantly higher concentration in the splenic suspension
of our FX-SH group compared to our WD-TBI and CO-
TX groups. This also is supported by earlier results as inMediators of Inﬂammation 5
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Figure 3: Lymphocyte subpopulations (%). FX-SH: femur fracture and shock; WD-TBI: weight drop traumatic brain injury; CO-TX:
combined injuries.
CD-8+ cells [34]. While the same reasons as above for
the physiologic CD-56 ratio in our WD-TBI group may
be discussed, in the CO-TX group one more aspect needs
consideration: raised TNFα levels in a murine sepsis model
were associated with an increased ratio of NK cells [35, 36].
However, for CD-56+ cells as well as for CD-8+ cells, the
detailed mechanisms and reasons underlying the diﬀerences
found in our study cannot readily be explained. Further
experiments should focus on lymphocyte populations in
peripheral tissues after TBI and combined TBI and trauma
hemorrhage.
Mortality may just reﬂect the inﬂammatory changes
and/or trauma load [1, 12]. In humans, injury severity
clearly is associated with mortality. Likewise, injury severity
was associated with an increased inﬂammatory response
as measured by increased IL-6 levels. So was mortality,
an increased IL-6 level in multiply injured patients was
associated with increased mortality. IL-6 even was suggested
to be used for prognosis in severe trauma [2, 30]. In murine
models, other groups support the ﬁndings in humans and of
our study [12, 14, 37].
5. Conclusion
Our animal model of combined extremity fracture, shock,
and closed traumatic brain injury clearly showed that the
inﬂammatory response of the combined trauma is sever-
alfold elevated as compared to the respective monotrauma
in terms of humoral parameters. The almost physiological
ﬁndings for peripheral tissue lymphocyte populations in
the isolated TBI and in the combined trauma group as
compared to the signiﬁcantly elevated ratios of the trauma-
hemorrhagegrouparenotreadilyexplainedandneedfurther
evaluation. Mortality in our combined trauma model is
clearly associated with trauma load and inﬂammation and
such parallels the ﬁndings in multiple trauma patients. This
shows the value of our model for future investigations.
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